Speak directly to the analyst to clarify any post sales queries you may have.
The analyst has been monitoring the global molecular weight marker market and it is poised to grow by USD 307.59 mn during 2020-2024, progressing at a CAGR of 12% during the forecast period. This report on the global molecular weight marker market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by significant use of sds-page in therapeutic discoveries and developments. In addition, emergence of microfluidic chip electrophoresis is anticipated to boost the growth of the global molecular weight marker market as well.
Market Segmentation
The global molecular weight marker market is segmented as below:
Product
- DNA Marker
- Protein Marker
- RNA Marker
Geographic segmentation
- Asia
- Europe
- North America
- ROW
Key Trends for global molecular weight marker market growth
This study identifies emergence of microfluidic chip electrophoresis as the prime reasons driving the global molecular weight marker market growth during the next few years.
Prominent vendors in global molecular weight marker market
We provide a detailed analysis of around 25 vendors operating in the global molecular weight marker market, including some of the vendors such as Abcam Plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Takara Bio Inc. and Thermo Fisher Scientific Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Table of Contents
01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Value chain analysis
04: MARKET SIZING
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market Outlook
05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- DNA marker - Market size and forecast 2019-2024
- Protein marker - Market size and forecast 2019-2024
- RNA marker - Market size and forecast 2019-2024
- Market opportunity by product
07: CUSTOMER LANDSCAPE
08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
09: DECISION FRAMEWORK
10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
11: MARKET TRENDS
- Availability of improved molecular weight markers
- Emergence of microfluidic chip electrophoresis
- Focus on reuse of molecular weight markers for cost-effective gel
- electrophoresis
12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abcam Plc
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- New England Biolabs Inc.
- Promega Corp.
- QIAGEN NV
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors key offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: DNA marker - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: DNA marker - Year-over-year growth 2020-2024 (%)
Exhibit 22: Protein marker - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Protein marker - Year-over-year growth 2020-2024 (%)
Exhibit 24: RNA marker - Market size and forecast 2019-2024 ($ millions)
Exhibit 25: RNA marker - Year-over-year growth 2020-2024 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2019-2024 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abcam Plc - Vendor overview
Exhibit 47: Abcam Plc - Business segments
Exhibit 48: Abcam Plc - Organizational developments
Exhibit 49: Abcam Plc - Geographic focus
Exhibit 50: Abcam Plc - Key offerings
Exhibit 51: Agilent Technologies Inc. - Vendor overview
Exhibit 52: Agilent Technologies Inc. - Business segments
Exhibit 53: Agilent Technologies Inc. - Organizational developments
Exhibit 54: Agilent Technologies Inc. - Geographic focus
Exhibit 55: Agilent Technologies Inc. - Segment focus
Exhibit 56: Agilent Technologies Inc. - Key offerings
Exhibit 57: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 58: Bio-Rad Laboratories Inc. - Business segments
Exhibit 59: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 60: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 61: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 62: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 63: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 64: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 65: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 66: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 67: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 68: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 69: Merck KGaA - Vendor overview
Exhibit 70: Merck KGaA - Business segments
Exhibit 71: Merck KGaA - Organizational developments
Exhibit 72: Merck KGaA - Geographic focus
Exhibit 73: Merck KGaA - Segment focus
Exhibit 74: Merck KGaA - Key offerings
Exhibit 75: New England Biolabs Inc. - Vendor overview
Exhibit 76: New England Biolabs Inc. - Product segments
Exhibit 77: New England Biolabs Inc. - Organizational developments
Exhibit 78: New England Biolabs Inc. - Key offerings
Exhibit 79: Promega Corp. - Vendor overview
Exhibit 80: Promega Corp. - Business segments
Exhibit 81: Promega Corp. - Key offerings
Exhibit 82: QIAGEN NV - Vendor overview
Exhibit 83: QIAGEN NV - Product segments
Exhibit 84: QIAGEN NV - Organizational developments
Exhibit 85: QIAGEN NV - Geographic focus
Exhibit 86: QIAGEN NV - Segment focus
Exhibit 87: QIAGEN NV - Key offerings
Exhibit 88: Takara Bio Inc. - Vendor overview
Exhibit 89: Takara Bio Inc. - Business segments
Exhibit 90: Takara Bio Inc. - Geographic focus
Exhibit 91: Takara Bio Inc. - Segment focus
Exhibit 92: Takara Bio Inc. - Key offerings
Exhibit 93: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 94: Thermo Fisher Scientific Inc. - Business segments
Exhibit 95: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 96: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 97: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 98: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 99: Validation techniques employed for market sizing
Exhibit 100: Definition of market positioning of vendors
Executive Summary
The following companies as the key players in the global molecular weight marker market: Abcam Plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Takara Bio Inc. and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is emergence of microfluidic chip electrophoresis”
According to the report, one of the major drivers for this market is the significant use of sds-page in therapeutic discoveries and developments.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abcam Plc
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- New England Biolabs Inc.
- Promega Corp.
- QIAGEN NV
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
